Thomas Schürpf

4PUBLICATIONS
23CO-AUTHORS
Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 09, 2024
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis.

Justin W Jackson, Frederick C Streich, Ajai Pal

|Jun 16, 2023
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer.

Junquan Liu, Huai-Chin Chiang, Wei Xiong

|Mar 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors.

Brian T Welsh, Ryan Faucette, Sanela Bilic

|Mar 28, 2020
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.

Constance J Martin, Abhishek Datta, Christopher Littlefield

Pageof 1

Frequent Collaborators

2 joint publications

Kevin B Dagbay

2 joint publications

Frederick C Streich

2 joint publications

Christopher Boston

2 joint publications

Justin W Jackson